Výsledky vyhledávání - Martha Arellano

Upřesnit hledání
  1. 1
    Current advances in identification of cancer biomarkers in saliva

    Current advances in identification of cancer biomarkers in saliva Autor Martha Arellano

    Vydáno 2009
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience

    Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience Autor Martha Arellano, Amelia Langston, Elliott F. Winton, Christopher R. Flowers, Edmund K. Waller

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer

    Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer Autor Martha Arellano-Garcia, Roger Li, Xiaojun Liu, Yongming Xie, Xiaofei Yan, Joseph A. Loo, Shen Hu

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays

    Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays Autor Shen Hu, Arjan Vissink, Martha Arellano, Caroline Roozendaal, Hui Zhou, Cees G. M. Kallenberg, David T. Wong

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Salivary Proteomics for Oral Cancer Biomarker Discovery

    Salivary Proteomics for Oral Cancer Biomarker Discovery Autor Shen Hu, Martha Arellano, Pinmanee Boontheung, Jianghua Wang, Hui Zhou, Jiang Jiang, David Elashoff, Roger Wei, Joseph A. Loo, David T. Wong

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Preclinical validation of salivary biomarkers for primary Sjögren's syndrome

    Preclinical validation of salivary biomarkers for primary Sjögren's syndrome Autor Shen Hu, Kai Gao, Rodney Pollard, Martha Arellano-Garcia, Hui Zhou, Lei Zhang, David Elashoff, Cees G. M. Kallenberg, Arjan Vissink, David T. Wong

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Electrochemical Sensor for Multiplex Biomarkers Detection

    Electrochemical Sensor for Multiplex Biomarkers Detection Autor Wei Fang, Prabhudas S. Patel, Wei Liao, Kishore Chaudhry, Lei Zhang, Martha Arellano-Garcia, Shen Hu, David Elashoff, Hui Zhou, Shilin N. Shukla, Franky D. Shah, Chih‐Ming Ho, David T. Wong

    Vydáno 2009
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin

    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin Autor Shannon Elf, Richard Z. Lin, Siyuan Xia, Yaozhu Pan, Changliang Shan, Shengjie Wu, Sagar Lonial, Manila Gaddh, Martha Arellano, H. Jean Khoury, Fadlo R. Khuri, Brendan Lee, Titus J. Boggon, Jun Fan, J Chen

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease Autor H. Jean Khoury, Amelia Langston, Vamsi Kota, Jennifer A. Wilkinson, Iskra Pusic, Anand Jillella, Stephanie Bauer, Audrey S Kim, Danielle Roberts, Zaid Al‐Kadhimi, Imre Bodó, Elliott F. Winton, Martha Arellano, John F. DiPersio

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

    Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101) Autor Eytan M. Stein, Ibrahim Aldoss, John F. DiPersio, Richard M. Stone, Martha Arellano, Galit Rosen, Michael L. Meyers, Yifan Huang, Steve Smith, Rebecca G. Bagley, Michael J. Thirman, Manish R. Patel, Ghayas C. Issa

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

    A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias Autor H. Jean Khoury, Guillermo Garcia‐Manero, Gautam Borthakur, Tapan Kadia, Maria Cielo Foudray, Martha Arellano, Amelia Langston, Beverly Bethelmie‐Bryan, Selena Rush, Kevin Litwiler, Sharon Karan, Heidi Simmons, Adam I. Marcus, Mieke Ptaszynski, Hagop M. Kantarjian

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth

    Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth Autor Changliang Shan, Hee‐Bum Kang, Shannon Elf, Jianxin Xie, Ting-Lei Gu, Mike Aguiar, Scott Lonning, Taro Hitosugi, Tae‐Wook Chung, Martha Arellano, H. Jean Khoury, Dong M. Shin, Fadlo R. Khuri, Titus J. Boggon, Jun Fan

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study Autor Daniel A. Pollyea, Keith W. Pratz, Anthony Letai, Brian A. Jonas, Andrew H. Wei, Vinod Pullarkat, Marina Konopleva, Michael J. Thirman, Martha Arellano, Pamela S. Becker, Brenda Chyla, Wan‐Jen Hong, Qi Jiang, Jalaja Potluri, Courtney D. DiNardo

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors

    Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors Autor Hagop M. Kantarjian, Harry P. Erba, David F. Claxton, Martha Arellano, Roger M. Lyons, T.J. Kovascovics, Janice Gabrilove, Michael Craig, Dan Douer, Michael B. Maris, Stephen H. Petersdorf, Paul J. Shami, Andrew M. Yeager, Stephen Eckert, Rekha Abichandani, Stefan Faderl

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect

    Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect Autor Jun Fan, Hee‐Bum Kang, Changliang Shan, Shannon Elf, Ruiting Lin, Jianxin Xie, Ting‐Lei Gu, Mike Aguiar, Scott Lonning, Tae‐Wook Chung, Martha Arellano, H. Jean Khoury, Dong M. Shin, Fadlo R. Khuri, Titus J. Boggon, Sumin Kang, Jing Chen

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia

    International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia Autor Gail J. Roboz, Todd Rosenblat, Martha Arellano, Marco Gobbi, Jessica K. Altman, Pau Montesinos, Casey L. O’Connell, Scott R. Solomon, Arnaud Pigneux, Norbert Vey, Robert K. Hills, Tove Flem Jacobsen, Athos Gianella-Borradori, Øivind Foss, Sylvia Vetrhusand, Francis J. Giles

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

    Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Autor Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat, Brian A. Jonas, Martha Arellano, Pamela S. Becker, Olga Frankfurt, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Tu Xu, Wan-Jen Hong, Brenda Chyla, Jalaja Potluri, Daniel A. Pollyea, Anthony Letai

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations

    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations Autor Daniel A. Pollyea, Courtney D. DiNardo, Martha Arellano, Arnaud Pigneux, Walter Fiedler, Marina Konopleva, David A. Rizzieri, B. Douglas Smith, Atsushi Shinagawa, Roberto M. Lemoli, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Hagop M. Kantarjian

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

    Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study Autor Hagop M. Kantarjian, Stefan Faderl, Guillermo Garcia‐Manero, Selina M. Luger, Parameswaran Venugopal, Lori J. Maness, Meir Wetzler, Steven Coutré, Wendy Stock, David F. Claxton, Stuart L. Goldberg, Martha Arellano, Stephen A. Strickland, Karen Seiter, Gary J. Schiller, Elias Jabbour, Judy H. Chiao, William Plunkett

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results

    Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results Autor Jorge E. Cortés, Benjamin D. Smith, Eunice S. Wang, Akil Merchant, Vivian G. Oehler, Martha Arellano, Daniel J. DeAngelo, Daniel A. Pollyea, Mikkael A. Sekeres, Tadeusz Robak, Weidong Wendy, Mirjana Zeremski, M. Naveed Shaik, A. Douglas Laird, Ashleigh O’Connell, Geoffrey Chan, Mark A. Schroeder

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: